Fidelity Investments
ANRO icon

Fidelity Investments’s Alto Neuroscience ANRO Stock Holding History

Fidelity Investments’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Buy
6,325
+11
+0.2% +$254 ﹤0.01% 3750
2026
Q1 		$142K Sell
6,314
-60
-0.9% -$1.11K ﹤0.01% 3650
2025
Q4 		$113K Sell
6,374
-1,302
-17% -$16.4K ﹤0.01% 3694
2025
Q3 		$30.9K Sell
7,676
-621
-7% -$2.06K ﹤0.01% 4175
2025
Q2 		$18.3K Sell
8,297
-1,264,389
-99% -$3.01M ﹤0.01% 4322
2025
Q1 		$2.75M Buy
1,272,686
+7,140
+0.6% +$25.6K ﹤0.01% 2345
2024
Q4 		$5.35M Sell
1,265,546
-1,097,510
-46% -$6.85M ﹤0.01% 2130
2024
Q3 		$27M Buy
2,363,056
+32,040
+1% +$392K ﹤0.01% 1611
2024
Q2 		$24.9M Sell
2,331,016
-18,900
-0.8% -$246K ﹤0.01% 1569
2024
Q1 		$36.1M Buy
+2,349,916
New +$36.8M ﹤0.01% 1450

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Fidelity Investments's ANRO Position: Q2 2026 in Review

Fidelity Investments increased its Alto Neuroscience (ANRO) stake by 0.17% in Q2 2026, buying an estimated $254 and bringing the position to 6,325 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #3750.

Fidelity Investments first reported a position in ANRO in Q1 2024 and has held it in 10 quarters since. The position peaked at $36.1M in Q1 2024. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Fidelity Investments held 6,325 shares of Alto Neuroscience worth $167K as of Q2 2026.
  • Fidelity Investments bought 11 Alto Neuroscience shares in Q2 2026, an estimated $254.
  • Alto Neuroscience made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3750 holding.
  • Fidelity Investments first reported a position in Alto Neuroscience in Q1 2024 and has held it in 10 quarters since.
  • Fidelity Investments's Alto Neuroscience position peaked at $36.1M in Q1 2024.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.